Efficacy of pirtobrutinib in covalent BTK-inhibitor pre-treated relapsed / refractory mantle cell lymphoma: Additional patients and extended follow-up from the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Wang, M. L.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Eyre, T. A.; Cheah, C. Y.; Ujjani, C. S.; Koh, Y.; Izutsu, K.; Gerson, J. N.; Flinn, I. W.; Tessoulin, B.; Alencar, A. J.; Ma, S.; Lech-Maranda, E.; Rhodes, J. M.; Patel, K.; Woyach, J. A.; Lamanna, N.; Wang, Y.; Tam, C. S.; Seymour, J. F.; Munir, T.; Nagai, H.; Hernandez-Ilizaliturri, F.; Kumar, A.; Zelenetz, A. D.; Jain, P.; Nair, B.; Tsai, D. E.; Balbas, M.; Walgren, R. A.; Abada, P. B.; Wang, C.; Zhao, J.; Mato, A. R. |
| Abstract Title: | Efficacy of pirtobrutinib in covalent BTK-inhibitor pre-treated relapsed / refractory mantle cell lymphoma: Additional patients and extended follow-up from the phase 1/2 BRUIN study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 9368 |
| End Page: | 9372 |
| Language: | English |
| ACCESSION: | WOS:000893230302163 |
| DOI: | 10.1182/blood-2022-159425 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
